We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-14.25%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$797M
AUM Growth
-$92.7M
Cap. Flow
+$50.4M
Cap. Flow %
6.32%
Top 10 Hldgs %
71.8%
Holding
263
New
21
Increased
95
Reduced
94
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 4.57%
2 Healthcare 3.4%
3 Financials 2.23%
4 Communication Services 1.87%
5 Consumer Staples 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
101
Broadcom
AVGO
$2.01T
$588K 0.07%
23,140
+4,090
+21% +$96.5K
COST icon
102
Costco
COST
$423B
$586K 0.07%
2,878
+387
+16% +$86.4K
TDS icon
103
Telephone and Data Systems
TDS
$3.88B
$575K 0.07%
+17,682
New +$587K
PBF icon
104
PBF Energy
PBF
$7.86B
$568K 0.07%
17,388
+8,341
+92% +$337K
VTV icon
105
Vanguard Morningstar Value ETF
VTV
$192B
$563K 0.07%
5,746
+15
+0.3% +$1.58K
HON icon
106
Honeywell
HON
$77B
$561K 0.07%
4,503
-464
-9% -$63.3K
UNP icon
107
Union Pacific
UNP
$174B
$554K 0.07%
4,009
-438
-10% -$64.9K
BIIB icon
108
Biogen
BIIB
$30.6B
$551K 0.07%
1,831
+45
+3% +$14.4K
C icon
109
Citigroup
C
$227B
$541K 0.07%
10,391
-5,385
-34% -$341K
MNK
110
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$524K 0.07%
33,133
+11,745
+55% +$293K
TSN icon
111
Tyson Foods
TSN
$20.1B
$511K 0.06%
9,577
-1,817
-16% -$107K
TMO icon
112
Thermo Fisher Scientific
TMO
$222B
$501K 0.06%
2,238
+46
+2% +$10.8K
MS icon
113
Morgan Stanley
MS
$338B
$488K 0.06%
12,309
+1,865
+18% +$81.4K
VBR icon
114
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$482K 0.06%
4,222
+630
+18% +$79.7K
LOW icon
115
Lowe's Companies
LOW
$123B
$479K 0.06%
5,184
+295
+6% +$28.4K
ITW icon
116
Illinois Tool Works
ITW
$83.9B
$477K 0.06%
3,766
-251
-6% -$33.1K
MDT icon
117
Medtronic
MDT
$114B
$472K 0.06%
5,193
+344
+7% +$32.1K
IWV icon
118
iShares Russell 3000 ETF
IWV
$20.4B
$470K 0.06%
3,197
-176
-5% -$28K
PYPL icon
119
PayPal
PYPL
$50.5B
$466K 0.06%
5,545
+21
+0.4% +$1.75K
GILD icon
120
Gilead Sciences
GILD
$165B
$463K 0.06%
7,397
-7,672
-51% -$536K
LNC icon
121
Lincoln National
LNC
$8.75B
$456K 0.06%
8,879
+2,132
+32% +$130K
OGS icon
122
ONE Gas
OGS
$4.96B
$456K 0.06%
5,733
-308
-5% -$25.4K
ULTA icon
123
Ulta Beauty
ULTA
$23.6B
$448K 0.06%
1,829
+676
+59% +$187K
SCHW
124
Charles Schwab
SCHW
$187B
$434K 0.05%
10,445
+31
+0.3% +$1.4K
FNDB icon
125
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.47B
$431K 0.05%
21,555
-2,538
-11% -$31.1K

Similar funds

Balasa Dinverno & Foltz's Q4 2018 Portfolio in Review

As of Q4 2018, Balasa Dinverno & Foltz held 263 positions worth $797M, down 10% from $890M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Balasa Dinverno & Foltz deployed $50.4M of net new capital in Q4 2018, opening 21 new positions and adding to 95 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 112,153 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 5.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $21.1M trimmed.

  • Balasa Dinverno & Foltz's largest Q4 2018 buy was iShares Russell 2000 Value ETF: 112,153 shares worth $12.1M.
  • Balasa Dinverno & Foltz added most to iShares MSCI EAFE Small-Cap ETF in Q4 2018, an estimated $21.1M increase.
  • Balasa Dinverno & Foltz's biggest Q4 2018 reduction was iShares National Muni Bond ETF, cutting an estimated $21.1M.
  • Balasa Dinverno & Foltz fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $849K.
  • Balasa Dinverno & Foltz's ten largest holdings make up 72% of its $797M portfolio in Q4 2018.
  • Balasa Dinverno & Foltz opened 21 new positions and closed 37 in Q4 2018.
  • Balasa Dinverno & Foltz's portfolio value fell 10% quarter-over-quarter to $797M.

Based on Balasa Dinverno & Foltz's 13F filing for Q4 2018, filed 4 Feb 2019.